Founded to close the distance between science and patients

A two-track model built for speed

Arbormed was founded to address unmet medical needs in rare and underserved disease, and to serve as a bridge for Korean pharmaceutical innovation entering the US market. The company pairs an innovative drug pipeline — sourced from academic and early-stage discoveries and advanced through internal R&D — with a complex generics business that generates nearer-term, de-risked revenue.